Posts tagged Distinguished Trustee and President Emeritus
David G. Nathan, M.D.

David G. Nathan, M.D., is a distinguished physician-researcher and pioneer in the field of pediatric hematology who has made numerous contributions to academic medicine. His research led to the creation of the first successful treatment for iron overload in thalassemia patients, the first prenatal diagnosis test for thalassemia and sickle cell disease, and the drug hydroxyurea—now a mainstay for managing the disease. Under his leadership, the Division of Pediatric Hematology/Oncology at Children’s Hospital Boston (CHB) and Dana-Farber Cancer Institute (DFCI) developed as the country’s premier pediatric hematology program. Prior to DFCI, he served as Chief of Hematology at CHB and the Chief of Hematology and Oncology at CHB and DFCI. Dr. Nathan served as Physician-In-Chief at BCH for 10 years before becoming DFCI’s President in 1995. He is one of only three physicians to receive both the Howland and Kober medals, and other awards include the inaugural Boston Children’s Hospital Lifetime Impact Award, the American Society of Hematology Henry M. Stratton Medal and its top recognition, the Wallace Coulter Award, as well as the National Medal of Science. Dr. Nathan is a member of the American Academy of Medicine, American Academy of Arts and Sciences and the American Philosophical Society. He received his M.D. from Harvard Medical School.

Read More